Tag: Richard Matheny
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
LATEST ON LAW.ASIA
In-house Counsel Awards 2026
Following months of market research, we have selected these outstanding in-house counsel and their teams
Japan outbound investment guide
Japanese corporates have been actively turning to the overseas M&A market for expanding their business and enhancing capital efficiency
